Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer

Abstract

PCDH17 promoter methylation was significantly associated with malignant behaviour and poor prognosis of bladder cancer. The detection of PCDH17 promoter methylation in serum-derived DNA may be a convenient and noninvasive predictive biomarker in routine clinical practice.